Lv35
310 积分 2023-05-08 加入
Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies
9天前
已完结
PI3KC2α inhibition is antithrombotic in blood from hypercholesterolemic mice
22天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
30天前
已完结
Lupus Nephritis: New and Emerging Biologic and Targeted Therapies
1个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1个月前
已完结
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus
1个月前
已完结
Anifrolumab: First Approval
1个月前
已完结
Telitacicept: First Approval
1个月前
已完结
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study
1个月前
已完结
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
1个月前
已完结
皖公网安备34019202002308
